Core capability areas for UK HEOR and market access analysts
Analysts working in the UK pharmaceutical or medical technology sector, especially in health economics and outcomes research (HEOR) and market access, need a broad mix of technical, analytical, and communication skills. The sections below summarise the most important capability areas.
1. Technical Proficiency in Data Analytics and Software
Statistical and data analysis tools: Expertise with SAS, STATA, R, Python, and SPSS is critical for analysing clinical trial data, real-world evidence (RWE), and health outcomes in NHS contexts.
Data management: Proficiency in handling large datasets, such as HES and CPRD, and skills in SQL for robust data extraction and transformation.
Health economics modelling: Familiarity with methods such as cost-utility analysis (CUA), budget impact analysis (BIA), and Markov models for evaluations submitted to organisations like NICE.
Excel proficiency: Strong spreadsheet skills remain important for financial modelling, sensitivity analysis, and communicating assumptions clearly.
2. Understanding of Health Economics and Outcomes Research (HEOR)
Economic evaluation: Working knowledge of UK-specific approaches, including QALYs, ICERs, and common NICE threshold conventions.
Real-world evidence (RWE): Ability to generate decision-ready evidence from NHS and related real-world data sources.
HTA pathways: Clear understanding of NICE, SMC, and AWMSG evidence expectations and appraisal logic.
3. Regulatory and Market Access Knowledge
UK pricing and reimbursement: Knowledge of frameworks such as VPAS and NHS procurement structures including the CMU.
HTA submissions: Familiarity with preparing and defending submissions, including technical query responses and evidence updates.
Policy analysis: Ability to assess how NHS reforms and reimbursement policy shifts affect access strategy.
4. Critical Thinking and Problem-Solving
Evidence synthesis: Critical appraisal of clinical and economic evidence across multiple sources for UK decision contexts.
Scenario analysis: Evaluation of alternative pricing, reimbursement, and policy futures.
Risk assessment: Identification of strategic reimbursement and access risks as guidance and policy evolve.
5. Communication and Presentation Skills
Value communication: Translate complex evidence into practical narratives for NHS commissioners, payer stakeholders, and appraisal bodies.
Scientific writing: Produce high-quality dossiers, reports, and manuscripts suitable for regulatory and HTA audiences.
Stakeholder engagement: Work effectively with decision-makers, reviewers, and clinical experts to align evidence with stakeholder needs.
6. Project Management and Cross-Functional Collaboration
Project delivery: Lead or support cross-functional initiatives such as HEOR studies and submission workstreams.
Coordination: Collaborate with medical, access, regulatory, commercial, and policy stakeholders around a shared evidence strategy.
7. Continuous Learning and Adaptability
Emerging trends: Keep pace with NHS structural changes, NICE evolution, and newer HEOR methods (including greater RWE usage).
Market context: Understand how UK reforms such as Integrated Care Systems (ICSs) and wider global shifts influence access planning.
Applied scenario
Consider an analyst supporting market access for a new biologic in rheumatoid arthritis. Typical responsibilities include building a robust cost-utility model with UK cost assumptions, preparing a coherent evidence narrative for NICE, and helping internal teams communicate budget impact to NHS stakeholders.
Developing these competencies strengthens decision quality in a complex healthcare environment and improves the effectiveness of market access and reimbursement strategy.